• ქართული
  • English
  • Merck's Keytruda meets main goal in pivotal lung cancer trial

    (Reuters) – Merck & Co said on Monday a late-stage trial of its blockbuster cancer drug Keytruda met the main goal in helping previously untreated lung cancer patients live longer, sending its shares up 2.6 percent in premarket trade.

    Market Quotes by TradingView